Deal Announcements

Aura Bio Collects Venture Capital Equity

Thursday, December 27, 2012 5:32:00 AM PDT | VentureDeal

   Cambridge, Massachusetts  --  Biotechnology company Aura Biosciences has secured $3.2 million in new venture capital equity investment, according to an SEC regulatory filing.

Aura says that it is a "next-generation biotech company...that is developing nano-selected drugs to inmates and treat tumor metastases."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1